Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AWR-PREP: Preoperative Optimization in Large Incisional Hernias
NCT07549113Recruiting
- Start
- Apr 2024
- Primary completion
- May 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of botulinum toxin type A in incisional hernia and ventral hernia (4 arms). Primary endpoint: Successful Midline Fascial Closure Rate. Started Apr 2024; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
incisional herniaventral hernia
Beyond the preview
Go deeper on NCT07549113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07549113.